id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-346777-zmmnn9b2	Lester, Sandra	Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies	2019-09-11		.txt	text/plain	5378	199	38	The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents Serological assays for emerging coronaviruses: challenges and pitfalls Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses Host cell entry of middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice Multiplex evaluation of influenza neutralizing antibodies with potential applicability to in-field serological studies Pseudotyped lentiviral vectors: one vector, many guises Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt Lack of MERS coronavirus neutralizing antibodies in humans, eastern Province, Saudi Arabia Evaluation of candidate vaccine approaches for MERS-CoV Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution Receptor variation and susceptibility to middle East respiratory syndrome coronavirus infection Proteolytic processing of middle East respiratory syndrome coronavirus spikes expands virus tropism Adaptive evolution of MERS-CoV to species variation in DPP4 Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein Development of a neutralization assay for Nipah virus using pseudotype particles The production and development of H7 influenza virus pseudotypes for the study of humoral responses against avian viruses Comparative serological assays for the study of H5 and H7 avian influenza viruses Safe pseudovirusbased assay for neutralization antibodies against influenza A(H7N9) virus Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26 Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus Reverse genetics with a full-length infectious cDNA of the middle East respiratory syndrome coronavirus Transgene expression in the genome of middle East respiratory syndrome coronavirus based on a novel reverse genetics system utilizing red-mediated recombination cloning Cross-Reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests The authors wish to acknowledge financial support from CDC LASSI 2016. Efficient packaging of MERS-CoV S on the surface of the VSV pseudoparticles and the ability of the pseudoparticles to enter target cells through receptor binding were confirmed by comparing the titrated inoculation of Vero and BHK-21 cells of negative control VSV pseudoparticles containing no viral glycoproteins on their surface (VSV-EV) with that for VSV pseudotyped with MERS-CoV-S proteins, designated VSV-MERS-S (Fig.	cache/cord-346777-zmmnn9b2.txt	txt/cord-346777-zmmnn9b2.txt
